Rapport Therapeutics, Inc. (RAPP) Operating cash flow 2023–2025
Rapport Therapeutics, Inc. (RAPP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$87.5MFY2025 · since FY2023: -$27.2M → -$87.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$87.5M | -34.9% |
| FY2024 | -$64.8M | -138.5% |
| FY2023 | -$27.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice